Quick Search

 

 


 

 

Home > Result Summaries: Compounds > fosamprenavir > Result Summary for APV102002

Result Summary for APV102002

Result Summary
Protocol ID: APV102002
Clinical Study ID: APV102002
Official Title: See Detailed Description
Phase: phase 3
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: fosamprenavir
Trade/Product Name: Telzir,Telzer,Lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Molina JM, Ait-Khaled M, Rinaldi R, et al. Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted, or standard dose fosamprenavir/ritonavir in patients with antiretroviral resistance. [J Antimicrob Chemother]. 2009;64(2):398-410.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.